Abstract
Cystinuria is an incompletely dominant disorder characterized by defective urinary cystine reabsorption that results in the formation of cystine-based urinary stones. Current treatment options are limited in their effectiveness at preventing stone recurrence and are often poorly tolerated. We report that the nutritional supplement α-lipoic acid inhibits cystine stone formation in the Slc3a1-/- mouse model of cystinuria by increasing the solubility of urinary cystine. These findings identify a novel therapeutic strategy for the clinical treatment of cystinuria.
Original language | English (US) |
---|---|
Pages (from-to) | 288-290 |
Number of pages | 3 |
Journal | Nature medicine |
Volume | 23 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1 2017 |
All Science Journal Classification (ASJC) codes
- Biochemistry, Genetics and Molecular Biology(all)